Mesoblast
MESO
26 hedge funds and large institutions have $13.3M invested in Mesoblast in 2019 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
13% more funds holding
Funds holding: 23 → 26 (+3)
0% less ownership
Funds ownership: 0.26% → 0.26% (-0%)
2% less capital invested
Capital invested by funds: $13.6M → $13.3M (-$300K)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $82K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$577K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$61.7K |
| 3 |
PCM
Princeton Capital Management
Red Bank,
New Jersey
|
+$37.2K |
| 4 |
AG
Aperio Group
Sausalito,
California
|
+$6.46K |
| 5 |
PP
Prudential plc
London, England,
United Kingdom
|
+$6.35K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$237K |
| 2 |
Renaissance Technologies
New York
|
-$182K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$122K |
| 4 |
Jane Street
New York
|
-$75K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
-$41K |
MESO Hedge Fund Activity: Q2 2019 in Review
26 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q2 2019, worth a combined $13.3M — down 2.2% from $13.6M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new MESO positions and 2 closed out — a net gain of 3 holders — while 5 added to existing stakes and 7 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $577K. The largest seller was Deutsche Bank, cutting an estimated $237K.
- 26 institutional investors held Mesoblast (MESO) as of Q2 2019, up from 23 in Q1 2019.
- Funds reported $13.3M of Mesoblast stock for Q2 2019, down 2.2% quarter-over-quarter.
- 5 funds opened new Mesoblast positions in Q2 2019 and 2 closed out, a net change of +3 holders.
- The largest Mesoblast buyer in Q2 2019 was Morgan Stanley, an estimated $577K added.
- The largest Mesoblast seller in Q2 2019 was Deutsche Bank, an estimated $237K sold.
Based on aggregated 13F filings for Q2 2019.